A study conducted at Toronto Western Hospital found no significant differences in discharge times from the operating room between patients with severe obesity and obstructive sleep apnea who received sugammadex or neostigmine during bariatric surgery. The study included 120 adults who underwent elective bariatric surgery with general anesthesia. Results showed no significant difference in operating room discharge times, duration from drug administration to extubation, eye opening, or patient movement between the two groups. While other research suggests sugammadex may reduce postoperative respiratory events compared to neostigmine, this study focused on immediate, in-hospital outcomes. The study was published in Anesthesia & Analgesia on June 7, 2024, and was partly supported by a research grant from Merck Sharp & Dohme.
Source link
Sugammadex Didn’t Hasten Post Bariatric Surgery Discharge
